Traditionally, medicinal discovery has focused on small agents, but amino acid collaborations are progressively demonstrating traction. This new approach utilizes combining short amino acid chains with alternative biological modalities to confront intricate condition pathways. By leveraging the distinctive characteristics of amino acid sequences �